InsidersTradesSigma
Follow the Jiangsu Recbio Technology Co., Ltd. - B stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Operating in the Technology sector, Jiangsu Recbio Technology Co., Ltd. - B has recorded 5 insider filings. Market capitalisation: €3.2bn. The latest transaction was disclosed on 6 May 2026 (Sale). Among the most active insiders: LIU YONG. The full history is free.
5
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
3 ops.
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,577 of 28,752 companies
29.2
score / 100
Value11
Quality48
FCF yld-19%
Earn yld-19%
EV/EBITDA·
ROE-143%
Gross mgn88%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 May 2026
Declarations5 total
5 of 5 declarations
About Jiangsu Recbio Technology Co., Ltd. - B
Jiangsu Recbio Technology Co., Ltd. is a company focused on the development of biopharmaceutical technologies. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.